| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |